Lv11
24 积分 2024-08-08 加入
Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment
5小时前
已完结
Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
5小时前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
4个月前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
9个月前
已完结
Embracing cancer complexity: Hallmarks of systemic disease
11个月前
已完结
In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide
11个月前
已完结
Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells
1年前
已完结
In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells
1年前
已完结
皖公网安备34019202002308
